FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1950689 · Received January 6, 2011

Report

Report Number
2134265-2010-05734
Event Type
Injury
Date Received
January 6, 2011
Date of Event
December 23, 2009
Report Date
December 7, 2010
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS COMBINATION PRODUCT IF IMPLANTED, GIVE DATE - 2009. DEVICE EVALUATED BY MANUFACTURER - THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Additional Manufacturer Narrative · 1

DATE OF THIS REPORT - CORRECTED FROM (B)(6) 2010 TO (B)(6) 2010 ON INITIAL MFR REPORT# 2134265-2010-05734.

Description of Event or Problem · 1

SAME CASE AS MFR REPORT# 2134265-2010-05733, 2134265-2010-05735. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE; CHEST PAIN, ANGINA AND STENT "BLOCKAGE" OCCURRED. THE PATIENT PRESENTED WITH ANGINA. A TAXUS EXPRESS2 STENT OF UNKNOWN SIZE WAS PLACED IN THE LEFT CIRCUMFLEX ARTERY (LCX). THE PATIENT WAS PLACED ON PLAVIX. THREE MONTHS LATER THE PATIENT AGAIN WAS EXPERIENCING ANGINA AND A SECOND TAXUS EXPRESS2 STENT WAS PLACED IN A DE NOVO LESION IN THE LCX. THREE TO FOUR MONTHS AFTER THE SECOND PROCEDURE, THE PATIENT AGAIN WAS EXPERIENCING ANGINA A THIRD TAXUS EXPRESS2 STENT WAS PLACED IN ANOTHER DE NOVO LESION IN THE LCX. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PRIOR PLACED STENTS WERE NOTED TO BE PATENT DURING THE REINTERVENTIONS. APPROXIMATELY 3 MONTHS AFTER THE LAST STENT PLACEMENT IN (B)(6) OF 2009, THE PATIENT PRESENTED WITH ANGINA AND CHEST PAIN AND ALL THREE STENTS WERE "BLOCKED." CABG WAS PERFORMED WITH BYPASSES TO BOTH THE LEFT ANTERIOR DESCENDING ARTERY AND RIGHT CORONARY ARTERY. THE PATIENT WAS DISCHARGED AFTER 21 DAYS IN THE HOSPITAL. ONE YEAR LATER IN (B)(6) OF 2010, THE PATIENT PRESENTED WITH CHEST PAIN AND ANGINA. THE PATIENT IS BEING MEDICALLY MANAGED AND HAS BEEN PLACED IN AN OUTPATIENT ANGINA THERAPY PROGRAM. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT IS NOT AVAILABLE.

Description of Event or Problem · 1

SAME CASE AS MFR REPORT# 2134265-2010-05733, 2134265-2010-05735. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE; CHEST PAIN, ANGINA AND STENT "BLOCKAGE" OCCURRED. THE PATIENT PRESENTED WITH ANGINA. A TAXUS EXPRESS2 STENT OF UNKNOWN SIZE WAS PLACED IN THE LEFT CIRCUMFLEX ARTERY (LCX). THE PATIENT WAS PLACED ON PLAVIX. THREE MONTHS LATER THE PATIENT AGAIN WAS EXPERIENCING ANGINA AND A SECOND TAXUS EXPRESS2 STENT WAS PLACED IN A DE NOVO LESION IN THE LCX. THREE TO FOUR MONTHS AFTER THE SECOND PROCEDURE, THE PATIENT AGAIN WAS EXPERIENCING ANGINA A THIRD TAXUS EXPRESS2 STENT WAS PLACED IN ANOTHER DE NOVO LESION IN THE LCX. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PRIOR PLACED STENTS WERE NOTED TO BE PATENT DURING THE REINTERVENTIONS. APPROXIMATELY 3 MONTHS AFTER THE LAST STENT PLACEMENT IN (B)(6) 2009, THE PATIENT PRESENTED WITH ANGINA AND CHEST PAIN AND ALL THREE STENTS WERE "BLOCKED." CABG WAS PERFORMED WITH BYPASSES TO BOTH THE LEFT ANTERIOR DESCENDING ARTERY AND RIGHT CORONARY ARTERY. THE PATIENT WAS DISCHARGED AFTER (B)(6) IN THE HOSPITAL. ONE YEAR LATER IN (B)(6) 2010 THE PATIENT PRESENTED WITH CHEST PAIN AND ANGINA. THE PATIENT IS BEING MEDICALLY MANAGED AND HAS BEEN PLACED IN AN OUTPATIENT ANGINA THERAPY PROGRAM. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK432

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention